Residual disease in AML, a target that can move in more than one direction
- PMID: 24243851
- DOI: 10.1002/cyto.b.21140
Residual disease in AML, a target that can move in more than one direction
Comment on
-
Tumor heterogeneity makes AML a "moving target" for detection of residual disease.Cytometry B Clin Cytom. 2014 Jan;86(1):3-14. doi: 10.1002/cyto.b.21134. Epub 2013 Oct 21. Cytometry B Clin Cytom. 2014. PMID: 24151248 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
